The innate and T-cell mediated immune response during acute and chronic gammaherpesvirus infection

• Published in: Frontiers in cellular and infection microbiology 2023-03, Vol.13, p.1146381-1146381
• Main Authors: Rex, Viktoria, Zargari, Razieh, Stempel, Markus, Halle, Stephan, Brinkmann, Melanie M
• Format: Article
• Language: English
• Subjects: Animals; Antiviral Restriction Factors; Cellular and Infection Microbiology; EBV; Epstein-Barr Virus Infections; Gammaherpesvirinae - physiology; gammaherpesvirus; Herpesvirus 4, Human; Humans; Immunity; innate immunity; interferon; MHV68; Mice; NK cells; Persistent Infection
• ISSN: 2235-2988; 2235-2988
• DOI: 10.3389/fcimb.2023.1146381

Immediately after entry into host cells, viruses are sensed by the innate immune system, leading to the activation of innate antiviral effector mechanisms including the type I interferon (IFN) response and natural killer (NK) cells. This innate immune response helps to shape an effective adaptive T cell immune response mediated by cytotoxic T cells and CD4 T helper cells and is also critical for the maintenance of protective T cells during chronic infection. The human gammaherpesvirus Epstein-Barr virus (EBV) is a highly prevalent lymphotropic oncovirus that establishes chronic lifelong infections in the vast majority of the adult population. Although acute EBV infection is controlled in an immunocompetent host, chronic EBV infection can lead to severe complications in immunosuppressed patients. Given that EBV is strictly host-specific, its murine homolog murid herpesvirus 4 or MHV68 is a widely used model to obtain insights into the interaction between gammaherpesviruses and their host. Despite the fact that EBV and MHV68 have developed strategies to evade the innate and adaptive immune response, innate antiviral effector mechanisms still play a vital role in not only controlling the acute infection but also shaping an efficient long-lasting adaptive immune response. Here, we summarize the current knowledge about the innate immune response mediated by the type I IFN system and NK cells, and the adaptive T cell-mediated response during EBV and MHV68 infection. Investigating the fine-tuned interplay between the innate immune and T cell response will provide valuable insights which may be exploited to design better therapeutic strategies to vanquish chronic herpesviral infection.